Impaired Glucose Transport as a Cause of Decreased Insulin-Stimulated Muscle Glycogen Synthesis in Type 2 Diabetes
Open Access
- 22 July 1999
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 341 (4), 240-246
- https://doi.org/10.1056/nejm199907223410404
Abstract
Insulin resistance, a major factor in the pathogenesis of type 2 diabetes mellitus, is due mostly to decreased stimulation of glycogen synthesis in muscle by insulin. The primary rate-controlling step responsible for the decrease in muscle glycogen synthesis is not known, although hexokinase activity and glucose transport have been implicated. We used a novel nuclear magnetic resonance approach with carbon-13 and phosphorus-31 to measure intramuscular glucose, glucose-6-phosphate, and glycogen concentrations under hyperglycemic conditions (plasma glucose concentration, approximately 180 mg per deciliter [10 mmol per liter]) and hyperinsulinemic conditions in six patients with type 2 diabetes and seven normal subjects. In vivo microdialysis of muscle tissue was used to determine the gradient between plasma and interstitial-fluid glucose concentrations, and open-flow microperfusion was used to determine the concentrations of insulin in interstitial fluid. The time course and concentration of insulin in interstitial fluid were similar in the patients with diabetes and the normal subjects. The rates of whole-body glucose metabolism and muscle glycogen synthesis and the glucose-6-phosphate concentrations in muscle were approximately 80 percent lower in the patients with diabetes than in the normal subjects under conditions of matched plasma insulin concentrations. The mean (±SD) intracellular glucose concentration was 2.0±8.2 mg per deciliter (0.11±0.46 mmol per liter) in the normal subjects. In the patients with diabetes, the intracellular glucose concentration was 4.3±4.9 mg per deciliter (0.24±0.27 mmol per liter), a value that was 1/25 of what it would be if hexokinase were the rate-controlling enzyme in glucose metabolism. Impaired insulin-stimulated glucose transport is responsible for the reduced rate of insulin-stimulated muscle glycogen synthesis in patients with type 2 diabetes mellitus.Keywords
This publication has 27 references indexed in Scilit:
- Mechanisms of the kinetic defect in insulin action in obesity and NIDDMDiabetes, 1997
- Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDMDiabetes, 1996
- Regulation of Glucose-Transporter FunctionDiabetes Care, 1990
- Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance SpectroscopyNew England Journal of Medicine, 1990
- Insulin transport across capillaries is rate limiting for insulin action in dogs.Journal of Clinical Investigation, 1989
- An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects.Journal of Clinical Investigation, 1988
- Beta-Cell Deficiency, Insulin Resistance, or Both?New England Journal of Medicine, 1988
- Impaired Glucose Tolerance as a Disorder of Insulin ActionNew England Journal of Medicine, 1988
- Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDMDiabetes, 1988
- Correlation between muscle glycogen synthase activity and in vivo insulin action in man.Journal of Clinical Investigation, 1984